Immunohistochemical study of cell cycle regulatory proteins in intraductal breast carcinomas - a preliminary study

被引:15
作者
Chasle, J [1 ]
Delozier, T
Denoux, Y
Marnay, J
Michels, JJ
机构
[1] Ctr Francois Baclesse, Dept Pathol, F-14076 Caen 5, France
[2] Ctr Francois Baclesse, Dept Clin Oncol, F-14076 Caen 5, France
关键词
breast; ductal carcinoma in situ; cyclin A; cyclin D1; Ki-67; p53; p21(waf1); VNPI grade;
D O I
10.1016/S0959-8049(02)00774-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was to assess the levels of cell cycle regulatory proteins p21(waf1) (p21), p53, Cyclin A, Cyclin D1 and Ki-67 to see whether they correlated with recurrence-free survival (RFS). From 1982 to 1996, 50 patients aged less than 51 years underwent lumpectomy followed by radiotherapy for a pure ductal carcinoma in situ (DCIS). For each case, the following immunohistochemical stains were carried out: Ki-67, Cyclin A, Cyclin D1, p53 and p21(waf1) (p21). The percentage of positive nuclei was assessed. Multiple combinations of these factors were performed; in particular, we called the sum of Ki-67 and Cyclin A a global proliferation factor (GPF). Correlations with classical clinicopathological data were assessed. After a multivariate analysis, only GPF, Van Nuys Prognostic Index (VNPI) grade and mitotic index were independent predictive factors of recurrence in the whole population. In the population with close surgical margins, when the GPF level was less than the 25th percentile or more than the 75th percentile recurrence was low. In this preliminary study, GPF seems to be of interest to help in the decision process in the post-surgical management of the patient. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1363 / 1369
页数:7
相关论文
共 37 条
[1]  
Abbes M, 1997, B CANCER, V84, P135
[2]  
Alle KM, 1998, CLIN CANCER RES, V4, P847
[3]   Prediction of local recurrence of ductal carcinoma in situ of the breast using five histological classifications:: A comparative study with long follow-up [J].
Badve, S ;
A'Hern, RP ;
Ward, AM ;
Millis, RR ;
Pinder, SE ;
Ellis, IO ;
Gusterson, BA ;
Sloane, JP .
HUMAN PATHOLOGY, 1998, 29 (09) :915-923
[4]   Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: Analysis of European organization for research and treatment of cancer trial 10853 [J].
Bijker, N ;
Peterse, JL ;
Duchateau, L ;
Julien, JP ;
Fentiman, IS ;
Duval, C ;
Di Palma, S ;
Simony-Lafontaine, J ;
de Mascarel, I ;
van de Vijver, MJ .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (08) :2263-2271
[5]  
Bose S, 1996, ARCH PATHOL LAB MED, V120, P81
[6]  
Boyages J, 1999, CANCER, V85, P616, DOI 10.1002/(SICI)1097-0142(19990201)85:3<616::AID-CNCR12>3.3.CO
[7]  
2-Z
[8]  
Denoux Y, 2001, B CANCER, V88, P419
[9]   Effect of preoperative chemotherapy on the outcome of women with operable breast cancer [J].
Fisher, B ;
Bryant, J ;
Wolmark, N ;
Mamounas, E ;
Brown, A ;
Fisher, ER ;
Wickerham, DL ;
Begovic, M ;
DeCillis, A ;
Robidoux, A ;
Margolese, RG ;
Cruz, AB ;
Hoehn, JL ;
Lees, AW ;
Dimitrov, NV ;
Bear, HD .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) :2672-2685
[10]  
FISHER ER, 1995, CANCER-AM CANCER SOC, V75, P1310, DOI 10.1002/1097-0142(19950315)75:6<1310::AID-CNCR2820750613>3.0.CO